BFA
ABBV icon

Beacon Financial Advisory’s AbbVie ABBV Stock Holding History

Beacon Financial Advisory’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$879K Buy
4,042
+124
+3% +$27.5K 0.2% 139
2025
Q4 		$895K Sell
3,918
-5,880
-60% -$1.34M 0.21% 128
2025
Q3 		$2.27M Buy
9,798
+626
+7% +$127K 0.53% 35
2025
Q2 		$1.7M Buy
9,172
+405
+5% +$75.3K 0.44% 47
2025
Q1 		$1.84M Buy
8,767
+63
+0.7% +$12.2K 0.56% 35
2024
Q4 		$1.55M Buy
8,704
+336
+4% +$61.8K 0.5% 44
2024
Q3 		$1.65M Buy
8,368
+157
+2% +$29.3K 0.56% 38
2024
Q2 		$1.41M Buy
8,211
+713
+10% +$118K 0.53% 38
2024
Q1 		$1.37M Sell
7,498
-11
-0.1% -$1.9K 0.66% 29
2023
Q4 		$1.16M Buy
7,509
+6
+0.1% +$875 0.56% 42
2023
Q3 		$1.12M Buy
7,503
+250
+3% +$36.7K 0.62% 42
2023
Q2 		$977K Buy
7,253
+16
+0.2% +$2.35K 0.56% 51
2023
Q1 		$1.15M Buy
7,237
+215
+3% +$32.9K 0.73% 32
2022
Q4 		$1.13M Sell
7,022
-42
-0.6% -$6.44K 0.81% 30
2022
Q3 		$948K Sell
7,064
-3,335
-32% -$479K 0.68% 43
2022
Q2 		$1.59M Buy
10,399
+353
+4% +$53.9K 0.91% 27
2022
Q1 		$1.63M Sell
10,046
-123
-1% -$17.9K 0.78% 33
2021
Q4 		$1.38M Sell
10,169
-90
-0.9% -$10.6K 0.64% 41
2021
Q3 		$1.11M Buy
10,259
+2,809
+38% +$321K 0.58% 49
2021
Q2 		$839K Buy
7,450
+118
+2% +$13.3K 0.45% 74
2021
Q1 		$794K Sell
7,332
-2,792
-28% -$299K 0.45% 79
2020
Q4 		$1.08M Buy
10,124
+994
+11% +$95.5K 0.7% 41
2020
Q3 		$799K Sell
9,130
-2,754
-23% -$259K 0.69% 38
2020
Q2 		$1.17M Buy
11,884
+215
+2% +$18.9K 1.27% 25
2020
Q1 		$889K Sell
11,669
-4,466
-28% -$380K 1.13% 26
2019
Q4 		$1.43M Buy
+16,135
New +$1.34M 1.22% 22

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Beacon Financial Advisory's ABBV Position: Q1 2026 in Review

Beacon Financial Advisory increased its AbbVie (ABBV) stake by 3.2% in Q1 2026, buying an estimated $27.5K and bringing the position to 4,042 shares worth $879K. The position accounts for 0.2% of the portfolio, ranked #139.

Beacon Financial Advisory first reported a position in ABBV in Q4 2019 and has held it in 26 quarters since. The position peaked at $2.27M in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Beacon Financial Advisory held 4,042 shares of AbbVie worth $879K as of Q1 2026.
  • Beacon Financial Advisory bought 124 AbbVie shares in Q1 2026, an estimated $27.5K.
  • AbbVie made up 0.2% of Beacon Financial Advisory's portfolio in Q1 2026, its #139 holding.
  • Beacon Financial Advisory first reported a position in AbbVie in Q4 2019 and has held it in 26 quarters since.
  • Beacon Financial Advisory's AbbVie position peaked at $2.27M in Q3 2025.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Beacon Financial Advisory's 13F filing for Q1 2026, filed 27 Apr 2026.